Nature Communications (Jan 2020)

Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy

  • Hayley C. Affronti,
  • Aryn M. Rowsam,
  • Anthony J. Pellerite,
  • Spencer R. Rosario,
  • Mark D. Long,
  • Justine J. Jacobi,
  • Anna Bianchi-Smiraglia,
  • Christoph S. Boerlin,
  • Bryan M. Gillard,
  • Ellen Karasik,
  • Barbara A. Foster,
  • Michael Moser,
  • John H. Wilton,
  • Kristopher Attwood,
  • Mikhail A. Nikiforov,
  • Gissou Azabdaftari,
  • Roberto Pili,
  • James G. Phillips,
  • Robert A. Casero,
  • Dominic J. Smiraglia

DOI
https://doi.org/10.1038/s41467-019-13950-4
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 15

Abstract

Read online

Prostate cancer cells depend on MTAP, the rate-limiting enzyme involved in the methionine salvage pathway, to cope with increased polyamine biosynthesis. Here, the authors show that inducing upregulation of polyamine biosynthesis and targeting MTAP synergize to increase apoptosis in prostate cancer cells.